ESTRO PT 2018

Challenges for new centers

Increase in number of centres

Historical niche will not fill to full capacity Common cancer sites will have to be treated

Superior beam but

level-I clinical evidence is lacking Non-randomized comparative evidence is scarce How choosing candidate cancers? How dealing with cost and reimbursement

Bridging the gap with photons Hypofractionation (protons) Combination therapy Exploiting immunogenic effects This course: overview of clinical data with emphasis on comparative assessments